Expert faculty review and share their insights and perspectives on key findings in multiple myeloma from ASH 2020.
In this commentary, 2 experts discuss their top presentation choices at ASH 2020 in myeloma with the most potential to impact clinical practice.
Two experts discuss results from key studies in multiple myeloma from the virtual Hematology 2020 meeting, including updated data on treatment options for newly diagnosed disease and an analysis of available agents for relapsed/refractory myeloma.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.